Physician profile
Chikamuche Anyanwu
NPI 1386107423
$2,384.57
in general payments reported to CMS, 2019-2025
10 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $395 · 2023: $961 · 2024: $784 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,989.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $1,182.42 | 2023-2025 | Symphony Catheter |
| Truvic Medical, INC. | $394.76 | 2022 | |
| Canon Medical Systems USA, INC. | $176.42 | 2024 | Interventional Angiography System |
| Boston Scientific Corporation | $167.46 | 2023-2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Inari Medical, INC. | $147.91 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Trisalus Life Sciences, INC. | $125.00 | 2024 | Trinav Infusion System |
| Sirtex Medical INC | $96.28 | 2023 | Sir-Spheres Microspheres |
| Mozarc Medical US LLC | $46.34 | 2025 | Palindrome |
| Teleflex LLC | $25.86 | 2025 | Arrow |
| Progenics Pharmaceuticals, INC. | $22.12 | 2023 | Pylarify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chikamuche Anyanwu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.